An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Eucrisa

Chemical Namecrisaborole
Dosage FormOintment (topical; 2%)
Drug ClassInhibitors
SystemSkin
CompanyAnacor Pharms Inc.
Approval Year2016

Indication

  • For topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
Last updated on 12/23/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Eucrisa (crisaborole) Prescribing Information 2020Pfizer Labs, NY NY
Document TitleYearSource
Crisaborole ointment, 2%, for treatment of patients with mild-to-moderate atopic dermatitis: Systematic literature review and network meta-analysis.2020Dermatology and Therapy
Application of topical phosphodiesterase 4 inhibitors in mild to moderate atopic dermatitis: a systematic review and meta-analysis.2019JAMA Dermatology